Query: NC_008825:3298506 Methylibium petroleiphilum PM1, complete genome Lineage: Methylibium petroleiphilum; Methylibium; ; Burkholderiales; Proteobacteria; Bacteria General Information: Methylibium petroleiphilum strain PM1 (ATCC BAA-1232) was isolated in 1998 from the biofilter of a treatment plant in an oil refinery in Los Angeles, California, USA. Strain PM1 is capable of degrading aromatic compounds such as benzene, toluene and xylenes. Methyl tertiary-butyl ether-degrading bacterium. Methylibium petroleiphilum is a methylotroph (able to utilize reduced one-carbon compounds) able to degrade methyl tertiary-butyl ether (MTBE) under aerobic conditions. MTBE is a gasoline additive used as an oxygenate and to raise the octane number.
- Sequence; - BLASTN hit (Low score = Light, High score = Dark) - hypothetical protein; - cds: hover for description
General Information: Rhodococcus erythropolis PR4 (NBRC 100887) was isolated from Pacific Ocean seawater. It has the enzymes necessary for the degradation of different alkanes, such as pristane. PR4 shows tolerance to hydrocarbons and it is capable of producing several compounds with medical, industrial, and nutritional applications such as beta-carotenes (i.e. astaxanthin) and fatty acid-containing extracellular polysaccharides (i.e. mucoidan). Rhodococcus species are soil bacteria with remarkable metabolic versatility leading to several possible applications in the pharmaceutical and chemical industries and for industrial bioremediation. This species has shown potential in producing different valuable compounds. As examples, some Rhodococcus erythropolis strains posses a nitrile hydratase, an enzyme used for the industrial production of acrylamide and nicotinamide, while other strains are capable of transforming indene to 1,2-indandiol, a key precursor of the AIDS drug Crixivan.